The pharma industry's rep hits absolute. rock. bottom.
After two years of being pilloried by the president and lawmakers for drug pricing, sparking headlines about huge judgments levied for triggering the opioid epidemic (J&J) and hiding manipulated data during an FDA review (Novartis), it may come as no surprise to hear that the industry’s reputation has suffered some.
But it’s worse than that.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.